Dupilumab‐Induced Erythrodermic Psoriasiform Dermatitis in Chronic Actinic Dermatitis: Case Report and Innovative Treatment Approach
ABSTRACT The off‐label use of dupilumab has proven to be an effective treatment option for severe chronic actinic dermatitis (CAD). We present the first case of CAD presenting with dupilumab‐induced erythrodermic psoriasiform dermatitis. A modified, spaced dupilumab dosing regimen, combined with cyc...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley
2024-11-01
|
| Seri Bilgileri: | Clinical Case Reports |
| Konular: | |
| Online Erişim: | https://doi.org/10.1002/ccr3.9590 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|